QA: Sio Gene Therapies Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001636050_2019_Sio_Gene_Therapies_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001636050, Sio Gene Therapies Inc

  xvar xval
0 AssetsCurrent 158,262,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,524,000
3 remainder_Assets 0
4 LiabilitiesCurrent 46,575,000
5 LiabilitiesNoncurrent 42,925,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 71,906,000
9 ResearchAndDevelopmentExpense 141,412,000
10 remainder_Expenses 8,466,000
11 remainder_Revenues 0
12 remainder_NetIncome 211,000
13 remainder_ComprehensiveNetIncome -252,000
  yvar yval
0 Assets 160,786,000
1 Liabilities 89,500,000
2 Expenses 221,784,000
3 Revenues 0
4 StockholdersEquity 71,286,000
5 NetIncome -221,573,000
6 ComprehensiveNetIncome -221,699,000
7 BaseVar 236,266,500
8 EconomicCapitalRatiobeforeLimitedLiability -0.530
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution

Change over Time